Multiple drugsAnti-MDA5 antibody–positive interstitial lung disease and lack of efficacy: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1933卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28243-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：292 / 292

相关论文

共 50 条

[1] Multiple drugsAnti-MDA5 autoantibody-positive dermatomyositis and lack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 299 - 299
[2] Multiple drugsAnti‑MDA5 dermatomyositis and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1935 (1) : 286 - 287
[3] Multiple drugsAnti-MDA5-positive dermatomyositis associated rapidly progressive interstitial lung disease and no improvement: case report
Reactions Weekly, 2023, 1952 (1) : 232 - 232
[4] Multiple drugDecrease antibody response and lack of efficacy: 5 case reports
Reactions Weekly, 2023, 1954 (1) : 288 - 288
[5] Multiple drugsDrug-induced interstitial lung disease, pulmonary toxicity and lack of efficacy: 10 case reports
Reactions Weekly, 2023, 1979 (1) : 300 - 300
[6] AntineoplasticsDrug-induced interstitial lung disease and lack of efficacy : 2 case reports
Reactions Weekly, 2024, 2019 (1) : 50 - 50
[7] Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease
Kaenmuang, Punchalee
Navasakulpong, Asma
RESPIROLOGY CASE REPORTS, 2021, 9 (01):
[8] Management of MDA-5 antibody-positive dermatomyositis with interstitial lung disease-an Auckland case series
Dick, Michael
Martin, Julia
Tugnet, Nicola
RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (01)
[9] Efficacy of tofacitinib for slowly progressive interstitial lung disease in a patient with anti-MDA5 antibody-positive dermatomyositis
Takatani, Ayuko
Koga, Tomohiro
Fujita, Yuya
Fukui, Shoichi
Endo, Yushiro
Shimizu, Toshimasa
Kawakami, Atsushi
CLINICAL IMMUNOLOGY, 2020, 215
[10] Multiple drugsAlzheimer's disease or lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1920 (1) : 319 - 319

← 1 2 3 4 5 →